Sign up to save your podcasts
Or
Share E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E95: Rituximab or Cyclophosphamide in ANCA Vasculitis
Fun study this week from JAMA Network Open and the French Vasculitis Study Group. They used a target trial emulation (one of my favorites) to ask whether RTX > CYC in AAV (another one of my favorites). I tried to use this to compare between observational and randomized data.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018
View all episodes
By Michael Putman
4.9
111111 ratings
Fun study this week from JAMA Network Open and the French Vasculitis Study Group. They used a target trial emulation (one of my favorites) to ask whether RTX > CYC in AAV (another one of my favorites). I tried to use this to compare between observational and randomized data.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799018
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
496 Listeners
Rheumnow Podcast
118 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
Core IM | Internal Medicine Podcast
1,081 Listeners
Healio Rheuminations
119 Listeners
The Clinical Problem Solvers
514 Listeners
ACR on Air
67 Listeners
Around the Rheum
5 Listeners
Rheumatology For The Royal College
171 Listeners
RheumMadness Podcast
11 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Talking Rheumatology Research
1 Listeners
Talking Rheumatology
0 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
18 Listeners